Heather N. Reich

17.3k total citations · 5 hit papers
143 papers, 5.9k citations indexed

About

Heather N. Reich is a scholar working on Nephrology, Rheumatology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Heather N. Reich has authored 143 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Nephrology, 24 papers in Rheumatology and 22 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Heather N. Reich's work include Renal Diseases and Glomerulopathies (77 papers), Chronic Kidney Disease and Diabetes (55 papers) and Systemic Lupus Erythematosus Research (19 papers). Heather N. Reich is often cited by papers focused on Renal Diseases and Glomerulopathies (77 papers), Chronic Kidney Disease and Diabetes (55 papers) and Systemic Lupus Erythematosus Research (19 papers). Heather N. Reich collaborates with scholars based in Canada, United States and United Kingdom. Heather N. Reich's co-authors include James W. Scholey, Daniel Cattran, Sean J. Barbour, Andrew M. Herzenberg, Mark Haas, Jennifer C. Rodrigues, Michelle Hladunewich, Daniel C. Cattran, David Z.I. Cherney and Gavin Y. Oudit and has published in prestigious journals such as The Lancet, PLoS ONE and Diabetes Care.

In The Last Decade

Heather N. Reich

132 papers receiving 5.8k citations

Hit Papers

IgA Nephropathy 2017 2026 2020 2023 2017 2019 2021 2023 2024 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. IgA Nephropathy
    2017 366 citations Heather N. Reich et al. Clinical Journal of the American Society of Nephrology profile →
  2. Evaluating a New International Risk-Prediction Tool in IgA Nephropathy
    2019 281 citations Sean J. Barbour, Yusuke Suzuki et al. profile →
  3. IgA Nephropathy: Core Curriculum 2021
    2021 175 citations Carmen Ávila-Casado, Heather N. Reich et al. profile →
  4. Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
    2023 121 citations Richard Lafayette, Jürgen Floege et al. profile →
  5. The pathogenesis of IgA nephropathy and implications for treatment
    2024 43 citations Chee Kay Cheung, Suceena Alexander et al. Nature Reviews Nephrology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heather N. Reich Canada 43 3.8k 1.0k 1.0k 896 849 143 5.9k
Daniel C. Cattran Canada 38 3.2k 0.8× 830 0.8× 958 1.0× 543 0.6× 355 0.4× 86 5.2k
Daniel Cattran Canada 38 4.5k 1.2× 1.5k 1.5× 298 0.3× 340 0.4× 583 0.7× 84 5.7k
Richard Lafayette United States 33 2.2k 0.6× 432 0.4× 266 0.3× 518 0.6× 538 0.6× 156 4.5k
J. Ashley Jefferson United States 27 2.7k 0.7× 861 0.8× 273 0.3× 382 0.4× 560 0.7× 50 5.2k
Rosanna Coppo Italy 44 4.8k 1.3× 1.2k 1.2× 187 0.2× 277 0.3× 1.6k 1.9× 214 6.3k
Stephen M. Korbet United States 44 4.6k 1.2× 821 0.8× 206 0.2× 277 0.3× 825 1.0× 99 6.5k
Enrique Morales Spain 29 1.8k 0.5× 272 0.3× 1.1k 1.1× 701 0.8× 284 0.3× 201 4.5k
Franco Ferrario Italy 36 4.1k 1.1× 558 0.5× 374 0.4× 196 0.2× 1.3k 1.5× 99 7.1k
Kevin V. Lemley United States 36 3.5k 0.9× 442 0.4× 395 0.4× 401 0.4× 310 0.4× 100 5.4k
Gabriel Contreras United States 35 2.4k 0.6× 370 0.4× 242 0.2× 593 0.7× 1.2k 1.4× 85 4.9k

Countries citing papers authored by Heather N. Reich

Since Specialization
Citations

This map shows the geographic impact of Heather N. Reich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heather N. Reich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heather N. Reich more than expected).

Fields of papers citing papers by Heather N. Reich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heather N. Reich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heather N. Reich. The network helps show where Heather N. Reich may publish in the future.

Co-authorship network of co-authors of Heather N. Reich

This figure shows the co-authorship network connecting the top 25 collaborators of Heather N. Reich. A scholar is included among the top collaborators of Heather N. Reich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heather N. Reich. Heather N. Reich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rovin, Brad H., Jonathan Barratt, H. Terence Cook, et al.. (2025). KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV). Kidney International. 108(4). S1–S71. 4 indexed citations
2.
Cheung, Chee Kay, Suceena Alexander, Heather N. Reich, et al.. (2024). The pathogenesis of IgA nephropathy and implications for treatment. Nature Reviews Nephrology. 21(1). 9–23. 43 indexed citations breakdown →
3.
Makita, Yuko & Heather N. Reich. (2024). Pathogenic Immunoglobulin A-Producing Cells in Immunoglobulin A Nephropathy. Journal of Clinical Medicine. 13(17). 5255–5255.
4.
Barbour, Sean J., Fernando C. Fervenza, Paul Brenchley, et al.. (2023). Anti-PLA2R Antibody Levels and Clinical Risk Factors for Treatment Nonresponse in Membranous Nephropathy. Clinical Journal of the American Society of Nephrology. 18(10). 1283–1293. 21 indexed citations
5.
Zhang, Song‐Yang, et al.. (2023). Metformin triggers a kidney GDF15-dependent area postrema axis to regulate food intake and body weight. Cell Metabolism. 35(5). 875–886.e5. 43 indexed citations
6.
Hladunewich, Michelle, D C Cattran, Sanjeev Sethi, et al.. (2021). Efficacy of Rituximab in Treatment-Resistant Focal Segmental Glomerulosclerosis With Elevated Soluble Urokinase-Type Plasminogen Activator Receptor and Activation of Podocyte β3 Integrin. Kidney International Reports. 7(1). 68–77. 10 indexed citations
7.
Cherney, David Z.I., Claire C. J. Dekkers, Sean J. Barbour, et al.. (2020). Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial. The Lancet Diabetes & Endocrinology. 8(7). 582–593. 180 indexed citations
8.
Thompson, Aliza, Kevin Carroll, Lesley A. Inker, et al.. (2019). Proteinuria Reduction as a Surrogate End Point in Trials of IgA Nephropathy. Clinical Journal of the American Society of Nephrology. 14(3). 469–481. 161 indexed citations
9.
Almaani, Salem, Stephenie D. Prokopec, Jianying Zhang, et al.. (2019). Rethinking Lupus Nephritis Classification on a Molecular Level. Journal of Clinical Medicine. 8(10). 1524–1524. 23 indexed citations
10.
Canney, Mark, et al.. (2019). Disease-specific incident glomerulonephritis displays geographic clustering in under-serviced rural areas of British Columbia, Canada. Kidney International. 96(2). 421–428. 18 indexed citations
11.
Yao, Tony, Rohan John, Amirreza Haghighi, et al.. (2019). Integration of Genetic Testing and Pathology for the Diagnosis of Adults with FSGS. Clinical Journal of the American Society of Nephrology. 14(2). 213–223. 90 indexed citations
12.
Barbour, Sean, et al.. (2014). The need for improved uptake of the KDIGO glomerulonephritis guidelines into clinical practice in Canada: a survey of nephrologists. Clinical Kidney Journal. 7(6). 538–545. 14 indexed citations
13.
Cherney, David Z.I., Heather N. Reich, James W. Scholey, et al.. (2013). The effect of aliskiren on urinary cytokine/chemokine responses to clamped hyperglycaemia in type 1 diabetes. Diabetologia. 56(10). 2308–2317. 13 indexed citations
14.
Cherney, David Z.I., J. W. Scholey, Denis Daneman, et al.. (2012). Urinary markers of renal inflammation in adolescents with Type 1 diabetes mellitus and normoalbuminuria. Diabetic Medicine. 29(10). 1297–1302. 27 indexed citations
15.
Reich, Heather N., et al.. (2011). Grizzly Bear Population Augmentation In The Cabinet Mountains Of Northwest Montana Wayne Kasworm,* USDA Fish and Wildlife Service, Libby. 17. 53–53.
16.
Dillon, John, Michelle Hladunewich, William E. Haley, et al.. (2011). Rituximab therapy for Type I membranoproliferative glomerulonephritis. Clinical Nephrology. 77(4). 290–295. 22 indexed citations
17.
John, Rohan, Ana Konvalinka, Ana Tobar, et al.. (2010). Determinants of Long-Term Graft Outcome in Transplant Glomerulopathy. Transplantation. 90(7). 757–764. 38 indexed citations
18.
Oudit, Gavin Y., Heather N. Reich, Zamaneh Kassiri, et al.. (2007). Loss of Angiotensin-Converting Enzyme-2 (Ace2) Accelerates Diabetic Kidney Injury. American Journal Of Pathology. 171(2). 438–451. 215 indexed citations
19.
Page, Andrea, Heather N. Reich, Joyce Zhou, et al.. (2005). Endothelial Nitric Oxide Synthase Gene/Gender Interactions and the Renal Hemodynamic Response to Angiotensin II. Journal of the American Society of Nephrology. 16(10). 3053–3060. 19 indexed citations
20.
Reich, Heather N., et al.. (1985). Rhinocerebral mucormycosis in a diabetic ketoacidotic patient. Journal of Neurology. 232(2). 115–117. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel C. Cattran Breakdown of academic impact, for papers by Daniel Cattran Breakdown of academic impact, for papers by Richard Lafayette Breakdown of academic impact, for papers by J. Ashley Jefferson Breakdown of academic impact, for papers by Rosanna Coppo Breakdown of academic impact, for papers by Stephen M. Korbet Breakdown of academic impact, for papers by Enrique Morales Breakdown of academic impact, for papers by Franco Ferrario Breakdown of academic impact, for papers by Kevin V. Lemley Breakdown of academic impact, for papers by Gabriel Contreras
Rankless by CCL
2026